A Long-term Study of OPC-262 in Patients With Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 07 Jun 2017 Biomarkers information updated
- 12 Apr 2012 Actual end date Jul 2011 added as reported by ClinicalTrials.gov.
- 12 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.